<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Angelis Consulting Group | Mayer | Activity</title>
	<link>https://angelisconsulting.com/members/scentskin6/activity/</link>
	<atom:link href="https://angelisconsulting.com/members/scentskin6/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Mayer.</description>
	<lastBuildDate>Tue, 18 Aug 2026 02:10:41 -0500</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">beced8d4bd05219e2b664b43e1d21d88</guid>
				<title>Mayer posted an update: Understanding the Landscape: Multiple Myeloma Lawsuits, [&#133;]</title>
				<link>https://angelisconsulting.com/activity/p/36627/</link>
				<pubDate>Fri, 14 Aug 2026 10:34:50 -0500</pubDate>

									<content:encoded><![CDATA[<p>Understanding the Landscape: Multiple Myeloma Lawsuits, Allegations, and What Patients Should Know</p>
<p>Multiple myeloma (MM), a cancer of plasma cells in the bone marrow, represents approximately 1.8% of all brand-new cancer cases in the United States annually, according to the American Cancer Society. While improvements in treatment have actually&hellip;<span class="activity-read-more" id="activity-read-more-36627"><a href="https://angelisconsulting.com/activity/p/36627/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">8c09367333949e61514e459e7ae9b6a2</guid>
				<title>Mayer posted an update: Multiple Myeloma Lawsuits: What Patients Need to Know About [&#133;]</title>
				<link>https://angelisconsulting.com/activity/p/36433/</link>
				<pubDate>Fri, 14 Aug 2026 09:24:18 -0500</pubDate>

									<content:encoded><![CDATA[<p><strong>Multiple Myeloma Lawsuits: What Patients Need to Know About Legal Options, Evidence, and Compensation</strong> </p>
<p><em>A helpful, third‑person overview of the growing body of lawsuits connected to drugs and exposures connected with multiple myeloma (MM).</em></p>
<p>Introduction</p>
<p>Multiple myeloma&#8211; a cancer of plasma cells in the bone marrow&#8211; impacts a&hellip;<span class="activity-read-more" id="activity-read-more-36433"><a href="https://angelisconsulting.com/activity/p/36433/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6530cdd74cf66e8eda639a3e42679f8d</guid>
				<title>Mayer posted an update: Understanding the Landscape: Multiple Myeloma Lawsuits and [&#133;]</title>
				<link>https://angelisconsulting.com/activity/p/36380/</link>
				<pubDate>Fri, 14 Aug 2026 09:06:35 -0500</pubDate>

									<content:encoded><![CDATA[<p>Understanding the Landscape: Multiple Myeloma Lawsuits and Patient Safety Concerns</p>
<p>Multiple myeloma, a cancer of plasma cells in the bone marrow, remains a severe diagnosis, though improvements in treatment have actually substantially enhanced survival rates over the previous twenty years. As unique treatments like immunomodulatory drugs&hellip;<span class="activity-read-more" id="activity-read-more-36380"><a href="https://angelisconsulting.com/activity/p/36380/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">12c599768d0ab0557c82077fa4839989</guid>
				<title>Mayer became a registered member</title>
				<link>https://angelisconsulting.com/activity/p/36368/</link>
				<pubDate>Fri, 14 Aug 2026 09:03:41 -0500</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>